FOR IMMEDIATE RELEASE
FOR MORE INFORMATION CONTACT:
Kevin C. Richards
Industry Vice President, Reed Exhibitions
IBM to Sponsor and Present at PharmaDiscovery
Norwalk, CT - January 5, 2005 - PharmaDiscovery, an Elsevier event, is pleased to announce that IBM has become a Platinum Sponsor of this new event, May 10-12, 2005 at the Washington, D.C. Convention Center.
PharmaDiscovery, an even t for scientists by scientists, will convey the scientific expertise and global reach of Elsevier in a new, knowledge-based forum combining pure scientific insight with drug discovery technology.
“We are pleased to have IBM as our Platinum Sponsor,” said Kevin Richards, Vice President, Reed Exhibitions. “IBM’s commitment to the life sciences community, particularly in the drug discovery, development and delivery market, makes this a perfect collaboration, rich in scientific resource.”
In addition, IBM will be inviting some of its business partners from the drug discovery area to join them in the IBM Partners Pavilion. IBM Business Partners are some of the industry’s leading developers of applications for discovery research, providing applications to help identify, analyze, share and manage data.
“PharmaDiscovery is an excellent platform for IBM to show our commitment and breadth of both internal and Business Partner-led offerings to the Life Sciences community,” said Dr. Frank White III, Worldwide Marketing Manager for Discovery Solutions for IBM Healthcare and Life Sciences.
IBM will provide a guest speaker to the PharmaDiscovery Conference in a session titled Bioinformatics and data mining – algorithms for feature detection and annotation , presented by Dr Isidore Rigoutsos, Manager, Bioinformatics & Pattern Discovery Group,
The conference program has been developed by chairs and co-chairs to actively encourage scientific debate and audience participation. Presentations, lead by scientists, will focus on clear objectives and tackle key issues within each discipline. The conference will have daily sum-up sessions that will integrate and disseminate scientific knowledge, and relay the key points and conclusions from each session back to the entire audience, facilitating the exchange of information between chemists and biologists, and helping to break down drug discovery silos. For complete details on the conference program, speakers and session synopses visit, www.pharmadiscovery 2005.com
PharmaDiscovery will attract members of the academic and pharmaceutical scientific R&D communities, regulatory authorities and developers and suppliers of critical technologies. An exhibit hall will feature exhibitors in categories such as automation integration, chemistry-related products, contract research, sample preparation, microarray products, custom databases, lab equipment, proteomics, screening and assay tools. Exhibitors include: Apple Computer, Inc., Caliper, CambridgeSoft Corporation, CEM Corporation, ChromaVision Medical Systems, Inc., Drug Discovery Today, EMD Biosciences, Inc., Fujitsu
RBI US Life Science Group, sciencejobs.com, SelectScience, Visual Sonics and more.
Elsevier is the respected global leader in scientific, technical and medical products including the highly regarded journals Drug Discovery Today, Cell, Tetrahedron, the Lancet, and the renowned scientific information platform, ScienceDirect. Other endorsing Reed Elsevier groups focused on drug discovery solutions include the Reed Business Information Science Group (Drug Discovery & Development Magazine, Bioscience Technology, Scientific Computing & Instrumentation Magazine, Genomics & Proteomics, Laboratory Equipment and R&D Magazine), MDL, and ScienceJobs.com/New Scientist.
The event will be produced and managed by Reed Exhibitions, the world's leading organizer of business-to-business events. Reed events are held in 35 countries and are organized by 30 international offices serving 49 industries.
For more information about PharmaDiscovery, visit:
www.pharmadiscovery2005.com or contact Kevin C. Richards at (203) 840-6221
Last updated on: 27/08/2010